Publications

5532 Results

Toxicity in the adjuvant therapy of rectal cancer: A preliminary report of Intergropu 0114 (CALGB 9081).

Authors
J Teppper;M O'Connell;G Petroni;A Benson;J Macdonald;J Martenson;T Rich;H Stern
Journal / Conference
American Society of Clinical Oncology 15:210(#481)
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9040

Improved overall survival with chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG8892, RTOG8817, ECOG2388) randomized study.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley
Journal / Conference
4th International Conference on Head and Neck Cancer Abstract-Book:118(#240)
Year
1996
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Southwest Oncology Group studies in hormone-refractory prostate cancer.

Authors
MHA Hussain;B Blumenstein;M Eisenberger;ED Crawford
Journal / Conference
Seminars in Oncology 23(6)(Suppl.14):24-27
Year
1996
Research Committee(s)
Genitourinary

The prostate cancer prevention trial.

Authors
A Ryan
Journal / Conference
Prevention/Early Detection SIG Newsletter 6(3):1
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Single fraction high dose chemotherapy with or without total body irradiation (TBI) and an autologous bone marrow transplant (ABMT) for patients with relapsed/refractory Hodgkin's disease: High survival rate in chemoresistant disease. A Southwest Oncology Group (SWOG) trial.

Authors
PJ Stiff;J Unger;RI Fisher;A McCall;A Nademanee;K Blume;S Horning;SJ Forman
Journal / Conference
Blood 88(10)Suppl.1:485a(#1930)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9011

Report of workshop 5: Early high-dose chemotherapy.

Authors
RI Fisher
Journal / Conference
Annals of Oncology 7(Suppl.4):S131-S133
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7808

Evaluation and management of mantle cell lymphoma.

Authors
OW Press;TM Grogan;RI Fisher
Journal / Conference
Advances in Leukemia and Lymphoma 6(1):3-11
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Clinical course and therapy of mantle cell lymphoma.

Authors
RI Fisher;OW Press;TP Miller;DR Head
Journal / Conference
Principles and Practice of Oncology 10(6):1-7
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Mantle-cell lymphoma: Classification and therapeutic implications.

Authors
RI Fisher
Journal / Conference
Annals of Oncology 7(Suppl.6):S35-S39
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Lymphoma Classification - The gap between biology and clinical management is closing.

Authors
W Hiddemann;DL Longo;B Coiffier;RI Fisher;F Cabanillas;F Cavalli;LM Nadler;VT De Vita;A Lister;JO Armitage
Journal / Conference
Blood 88(11):4085-4089
Year
1996
Research Committee(s)
Lymphoma